Ramsden; Philip Dean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ramsden; Philip Dean.The latest application filed is for "substituted pyrimidinones as agonists of the apj receptor".

Company Profile

1.9.7

Ramsden; Philip Dean - Acton MA
Ramsden; Philip Dean - Woodbury CT
Ramsden; Philip Dean - Mount Vernon NY US
Ramsden; Philip Dean - Mt. Vernon NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Alkyl substituted triazole compounds as agonists of the APJ Receptor Grant 11,191,762 - Chen , et al. December 7, 2	2021-12-07
Substituted Pyrimidinones As Agonists Of The Apj Receptor App 20210246118 - PATTAROPONG; Vatee ; et al.	2021-08-12
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor Grant 11,020,395 - Chen , et al. June 1, 2	2021-06-01
Cycloalkyl Substituted Triazole Compounds As Agonists Of The Apj Receptor App 20190290648 - CHEN; Yinhong ; et al.	2019-09-26
Alkyl Substituted Triazole Compounds As Agonists Of The Apj Receptor App 20190290647 - CHEN; Yinhong ; et al.	2019-09-26
Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them Grant 8,859,814 - Cogan , et al. October 14, 2	2014-10-14
Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S Grant 8,729,114 - Burke , et al. May 20, 2	2014-05-20
2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 Grant 8,586,748 - Abeywardane , et al. November 19, 2	2013-11-19
Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S App 20130158018 - Burke; Michael J. ; et al.	2013-06-20
Alpha-substituted N-sulfonyl Gylcine Amides Antagonists Of Ccr10, Compositions Containing The Same And Methods For Using Them App 20110275612 - Cogan; Derek ; et al.	2011-11-10
2-sulfonylamino-4-heteroaryl Butyramide Antagonists Of Ccr10 App 20110275800 - Abeywardane; Asitha ; et al.	2011-11-10
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors Grant 7,790,712 - Cogan , et al. September 7, 2	2010-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.